Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Heron Therapeutics (HRTX) Long-Term Debt Issuances (2021)

Historic Long-Term Debt Issuances for Heron Therapeutics (HRTX) over the last 2 years, with Q3 2021 value amounting to -$19000.0.

  • Heron Therapeutics' Long-Term Debt Issuances changed N/A to -$19000.0 in Q3 2021 from the same period last year, while for Dec 2021 it was -$19000.0, marking a year-over-year change of. This contributed to the annual value of $149.0 million for FY2021, which is N/A changed from last year.
  • Heron Therapeutics' Long-Term Debt Issuances amounted to -$19000.0 in Q3 2021.
  • In the past 5 years, Heron Therapeutics' Long-Term Debt Issuances registered a high of -$19000.0 during Q3 2021, and its lowest value of -$19000.0 during Q3 2021.